Cronos Group Inc. (CRON)
Nasdaq · Healthcare · Drug Manufacturers - Specialty & Generic
$3.25+0.78%as of Oct 6, 2026, 4:35 AM ET
- Market cap
- $1.2B
- P/E (trailing)
- 17.1
- 52-week range
- $2.28 – $3.61
- 52-week change
- +23.09%
- EPS (trailing)
- $0.19
- Analyst rating
- 1.5 Strong buy
- Next earnings
- Nov 5, 2026
Fiscal year to Dec 2025
- Revenue
- $147M (+24.64%)
- Net income
- −$2.9M
- Operating margin
- −11.9%
- Diluted EPS
- −$0.02
- Free cash flow
- $150K
From the company’s annual report on SEC EDGAR.
About Cronos Group Inc.
Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names. The company is headquartered in Stayner, Canada.
Headquarters: Stayner, Canada · 610 employees · thecronosgroup.com